These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 974347)

  • 1. Structure activity studies on dopamine receptors; a comparison between rat striatal adenylate cyclase and Helix aspersa neurones [proceedings].
    Munday KA; Poat JA; Woodruff GN
    Br J Pharmacol; 1976 Jul; 57(3):452P-453P. PubMed ID: 974347
    [No Abstract]   [Full Text] [Related]  

  • 2. Adenosine-sensitive adenylate cyclase in rat striatal homogenates and its relationship to dopamine- and Ca2+-sensitive adenylate cyclases.
    Prémont J; Perez M; Bockaert J
    Mol Pharmacol; 1977 Jul; 13(4):662-70. PubMed ID: 887074
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings: Is metoclopramide a directly acting dopamine receptor antagonist?
    Donaldson IM; Jenner P; Marsden CD; Miller R; Peringer E
    Br J Pharmacol; 1976 Mar; 56(3):373P. PubMed ID: 1260201
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic sulpiride treatment produces supersensitivity of striatal adenylate cyclase to dopamine in sexually immature or adult castrated rats.
    Gnegy ME; Bernabei A; Treisman G
    J Pharmacol Exp Ther; 1983 Mar; 224(3):627-33. PubMed ID: 6827485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular dopamine receptor as a model for other dopamine receptors.
    Goldberg LI
    Adv Biochem Psychopharmacol; 1978; 19():119-29. PubMed ID: 358776
    [No Abstract]   [Full Text] [Related]  

  • 7. Similarities and differences of dopamine receptors in the renal vascular bed and elsewhere.
    Goldberg LI; Volkman PH; Kohli JD; Kotake AN
    Adv Biochem Psychopharmacol; 1977; 16():251-6. PubMed ID: 196488
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of calmodulin on dopamine-sensitive adenylate cyclase activity in rat striatal membranes.
    Gnegy M; Treisman G
    Mol Pharmacol; 1981 Mar; 19(2):256-63. PubMed ID: 7231389
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the effects of dopamine and beta-adrenergic agonists on adenylate cyclase of renal glomeruli and striatum.
    Kotake C; Hoffmann PC; Goldberg LI; Cannon JG
    Mol Pharmacol; 1981 Sep; 20(2):429-34. PubMed ID: 6117789
    [No Abstract]   [Full Text] [Related]  

  • 10. Topographical distribution and characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the rat frontal cerebral cortex, striatum, and substantia nigra.
    Bockaert J; Premont J; Glowinski J; Tassin JP; Thierry AM
    Adv Biochem Psychopharmacol; 1977; 16():29-37. PubMed ID: 196489
    [No Abstract]   [Full Text] [Related]  

  • 11. Repeated amphetamine pretreatment alters the responsiveness of striatal dopamine-stimulated adenylate cyclase to amphetamine-induced desensitization.
    Barnett JV; Segal DS; Kuczenski R
    J Pharmacol Exp Ther; 1987 Jul; 242(1):40-7. PubMed ID: 2956412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.
    Cooper DM; Bier-Laning CM; Halford MK; Ahlijanian MK; Zahniser NR
    Mol Pharmacol; 1986 Feb; 29(2):113-9. PubMed ID: 3005824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of adenylate cyclase in rat striatum by an ergoline dopamine agonist, pergolide.
    Wong DT; Reid LR
    Commun Psychopharmacol; 1980; 4(4):269-75. PubMed ID: 7273702
    [No Abstract]   [Full Text] [Related]  

  • 14. Catecholamine receptors on the neurones of Helix aspersa.
    Glaizner B
    J Physiol; 1968 Jul; 197(1):70P-71P. PubMed ID: 5675086
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography.
    Miller R; Horn A; Iversen L; Pinder R
    Nature; 1974 Jul; 250(463):238-41. PubMed ID: 4368645
    [No Abstract]   [Full Text] [Related]  

  • 16. Further characterization of structural requirements for agonists at the striatal dopamine D-1 receptor. Studies with a series of monohydroxyaminotetralins on dopamine-sensitive adenylate cyclase and a comparison with dopamine receptor binding.
    Seiler MP; Markstein R
    Mol Pharmacol; 1982 Sep; 22(2):281-9. PubMed ID: 7144729
    [No Abstract]   [Full Text] [Related]  

  • 17. Desensitization of rat striatal dopamine-stimulated adenylate cyclase after acute amphetamine administration.
    Barnett JV; Kuczenski R
    J Pharmacol Exp Ther; 1986 Jun; 237(3):820-5. PubMed ID: 2940359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
    Heijna MH; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
    J Pharmacol Exp Ther; 1989 Jun; 249(3):864-8. PubMed ID: 2543814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How do antipsychotic drugs work?
    Iversen LL
    Neurosci Res Program Bull; 1975 Aug; 13 Suppl():29-51. PubMed ID: 241033
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochemical and pharmacological studies on dopamine receptors.
    Woodruff GN
    Adv Biochem Psychopharmacol; 1978; 19():89-118. PubMed ID: 358789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.